Recently, the U.S. FDA approved esketamine, a fast-acting drug derived from the anesthetic, ketamine, that is intended to aid the treatment-resistant population of people with depression. There are about 16.2 million Americans who suffer from major depression, and as many as a quarter of them reported achieving little to […]
For nearly twelve years, scientists have been trying and failed to duplicate the procedure that led to the first ever successful HIV treatment of a patient in 2007. Their hard work seemed to have paid off when the news broke: a London patient was cured from the HIV […]
Migraine is experienced by 1 billion people globally, ranking as the third most common disease in the world. It is much more than just a bad headache, but a neurological condition that can be extremely incapacitating for sufferers. Migraine symptoms vary, but the most common is a severe, throbbing, recurring […]
ALL THIS boy wanted for Christmas was to honor his late best friend by giving him a headstone—and he did it with hard work, love, commitment, and dedication. It’s been almost five months since Kaleb Klakulak, 12 years old, lost his best friend Kenneth “KJ” Gross, who succumbed […]
